It is important to note that fitted median antigenaemia at time of treatment was fairly low compared to other studies (380,000 pg/mL pLDH and 28,000 pg/mL HRP2) [19], potentially because participants were being treated quickly as soon as symptomatic infection presented due to frequent study visits. This evidence concerns the gene HDGFL2 and infection.